You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
US researchers conducted a genome-wide association study of sexual orientation among men, but found only tentative links.
In PLOS this week: plague patterns in Kyrgyzstan, trypanosomiasis susceptibility variants, and more.
A growing number of companies are offering canine DNA tests for breed identification, genetic disease mutations, and traits.
Results from a randomized clinical trial known as GIFT suggest that genotype-guided warfarin dosing is linked to fewer adverse events than clinical dosing.
An international team of researchers said their set of 80 SNPs could be used to uniquely identify and track personal genome samples.
Earlier this week, the company launched Genomic Explorer in the US, a web-based service that enables consumers to upload their genomic data for viewing and analysis.
The Australian molecular diagnostics firm received 265 test samples during the quarter, including 140 tests issued to Ohio State University as part of an agreement.
Researchers identified truncating, psychosis-related mutations in RBM12 in a family affected by schizophrenia or other psychosis disorders.
Suspicious variants were uncovered through analyses of pediatric cancer survivors from the St. Jude Lifetime Cohort Study and Childhood Cancer Survivor Study.
The team performed a gene expression analysis to discover the new loci, bringing the total number of known risk loci associated with CAD to 73.
A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.
Nature News writes that viral genomic surveillance in the US faces systemic issues.
President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.
In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.